©The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Methodol. Sep 20, 2023; 13(4): 366-372
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.366
Published online Sep 20, 2023. doi: 10.5662/wjm.v13.i4.366
Sclerotic marginal zone lymphoma: A case report
Zade Moureiden, Hammad Tashkandi, Mohammad Omar Hussaini, Pathology and Laboratory Medicine, Moffitt Cancer Center, Tampa, FL 33612, United States
Author contributions: Moureiden Z, Tashkandi H, and Hussaini MO contributed to the conception and design of the study, acquisition and analysis of data; Moureiden Z and Hussaini MO drafted the manuscript or figures.
Informed consent statement: All study participants, or their legal guardian, provided informed written consent prior to study enrollment.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Corresponding author: Mohammad Omar Hussaini, MD, Associate Professor, Director, Pathology and Laboratory Medicine, Moffitt Cancer Center, 12902 USF Magnolia Drive, Tampa, FL 33612, United States. mohammad.hussaini@moffitt.org
Received: June 14, 2023
Peer-review started: June 14, 2023
First decision: July 7, 2023
Revised: August 4, 2023
Accepted: August 23, 2023
Article in press: August 23, 2023
Published online: September 20, 2023
Processing time: 97 Days and 11.6 Hours
Peer-review started: June 14, 2023
First decision: July 7, 2023
Revised: August 4, 2023
Accepted: August 23, 2023
Article in press: August 23, 2023
Published online: September 20, 2023
Processing time: 97 Days and 11.6 Hours
Core Tip
Core Tip: In the clinical context of suspicious lymphadenopathy, the presence of an extensive sclerosis on biopsy should not deter the clinician from a diagnosis of lymphoma, and careful evaluation and work up is needed to exclude covert lym